canyon landscape

Eli Lilly I5Q-MC-B002

Preventive Treatment of Migraine: Outcomes for Patients in Real-World Healthcare Systems (TRIUMPH)

The purpose of this study is to collect information about treatment patterns, effects, and outcomes in patients with migraine who are switching or initiating a pharmacologic treatment for migraine prevention. 

We anticipate that approximately 6000 patients will participate in this study. 

Status
Open and enrolling subjects.
Location
Phoenix, Arizona
Total Participants
6000
Primary Sponsor
Eli Lilly